Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

29 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

End of Therapy SirTac NCT02936388 - End of Therapy

- 28/11/2017 - 1 Formulário, 1 Grupo de itens, 12 Elementos de dados, 1 Idioma
Grupo de itens: Therapy end
Study part: End of Therapy. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Concomitant Medications GSK study Prostatic neoplasms NCT00883909

- 26/11/2017 - 1 Formulário, 3 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Administrative data, Concomitant Medications, Concomitant Medication
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate

Eligibility Nasopharyngeal Carcinoma NCT00592501

- 01/06/2017 - 1 Formulário, 2 Grupos de itens, 19 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00592501

Eligibility Nasopharyngeal Carcinoma NCT00677118

- 01/06/2017 - 1 Formulário, 2 Grupos de itens, 16 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00677118

Non-Surgical Intervention GSK study Prostatic neoplasms NCT00883909

- 26/11/2017 - 1 Formulário, 3 Grupos de itens, 12 Elementos de dados, 1 Idioma
Grupos de itens: Administrative data, Intervention non-surgical Prostate Cancer, Intervention non-surgical
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate

Protocol IIB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulário, 5 Grupos de itens, 28 Elementos de dados, 1 Idioma
Grupos de itens: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIB (Study Protocol IIB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IIIA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIIA AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulário, 4 Grupos de itens, 32 Elementos de dados, 1 Idioma
Grupos de itens: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIIA. Clinical Trial Number: NCT01117441.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulário, 5 Grupos de itens, 33 Elementos de dados, 1 Idioma
Grupos de itens: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulário, 4 Grupos de itens, 21 Elementos de dados, 1 Idioma
Grupos de itens: Patient Information, Chemotherapy Regimen, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Protocol IIA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIA AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulário, 5 Grupos de itens, 31 Elementos de dados, 1 Idioma
Grupos de itens: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIA. Clinical Trial Number: NCT01117441.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulário, 4 Grupos de itens, 21 Elementos de dados, 1 Idioma
Grupos de itens: Patient Information, Chemotherapy Regimen, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulário, 5 Grupos de itens, 28 Elementos de dados, 1 Idioma
Grupos de itens: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial